Literature DB >> 7139256

Murine motor neuron disease (the wobbler mouse): degeneration and regeneration of the lower motor neuron.

H Mitsumoto, W G Bradley.   

Abstract

The study of the temporospatial pattern of lower motor neuronal generation in the wr/wr mouse demonstrated that the pathological changes started in the neuronal perikaryon in the spinal cord. Thus the wr/wr mouse suffers from a primary motor neuronopathy. Axonal pathology predominated at the level of the ventral root and suggested a focal proximal axonopathy. Microtubular segregation, neurofilamentous accumulation in the axon, and axonal or adaxonal vacuoles appeared to be closely related to subsequent axonal degeneration. Large myelinated fibres in the cervical ventral roots progressively degenerated and diminished in number with age. On the other hand, significant axonal regeneration coincided, with the axonal degeneration in the cervical ventral roots. A dying-back type of degeneration and axonal atrophy were not present. This study demonstrated that a primary disease of the perikaryon may express itself as a focal proximal axonopathy characterized by axonal degeneration and attempted axonal regeneration.

Entities:  

Mesh:

Year:  1982        PMID: 7139256     DOI: 10.1093/brain/105.4.811

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  13 in total

1.  Muscle Yap Is a Regulator of Neuromuscular Junction Formation and Regeneration.

Authors:  Kai Zhao; Chengyong Shen; Yisheng Lu; Zhihui Huang; Lei Li; Christopher D Rand; Jinxiu Pan; Xiang-Dong Sun; Zhibing Tan; Hongsheng Wang; Guanglin Xing; Yu Cao; Guoqing Hu; Jiliang Zhou; Wen-Cheng Xiong; Lin Mei
Journal:  J Neurosci       Date:  2017-02-17       Impact factor: 6.167

2.  Reduction of lower motor neuron degeneration in wobbler mice by N-acetyl-L-cysteine.

Authors:  J T Henderson; M Javaheri; S Kopko; J C Roder
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

3.  The 21-aminosteroid U-74389F increases the number of glial fibrillary acidic protein-expressing astrocytes in the spinal cord of control and Wobbler mice.

Authors:  M C Gonzalez Deniselle; S L Gonzalez; G G Piroli; A E Lima; A F De Nicola
Journal:  Cell Mol Neurobiol       Date:  1996-02       Impact factor: 5.046

Review 4.  Cellular basis of steroid neuroprotection in the wobbler mouse, a genetic model of motoneuron disease.

Authors:  M C González Deniselle; S L González; A F De Nicola
Journal:  Cell Mol Neurobiol       Date:  2001-06       Impact factor: 5.046

Review 5.  The wobbler mouse: a neurodegeneration jigsaw puzzle.

Authors:  Séverine Boillée; Marc Peschanski; Marie-Pierre Junier
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

Review 6.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

7.  The 21-aminosteroid U-74389F attenuates hyperexpression of GAP-43 and NADPH-diaphorase in the spinal cord of wobbler mouse, a model for amyotrophic lateral sclerosis.

Authors:  M C González Deniselle; S L González; A E Lima; G Wilkin; A F De Nicola
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

Review 8.  Developmental and Functional Effects of Steroid Hormones on the Neuroendocrine Axis and Spinal Cord.

Authors:  L Zubeldia-Brenner; C E Roselli; S E Recabarren; M C Gonzalez Deniselle; H E Lara
Journal:  J Neuroendocrinol       Date:  2016-07       Impact factor: 3.627

9.  Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Luis B Tovar-Y-Romo; Luz Diana Santa-Cruz; Ricardo Tapia
Journal:  Mol Neurodegener       Date:  2009-07-20       Impact factor: 14.195

Review 10.  The wobbler mouse, an ALS animal model.

Authors:  Jakob Maximilian Moser; Paolo Bigini; Thomas Schmitt-John
Journal:  Mol Genet Genomics       Date:  2013-03-29       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.